GINA OWENS: Open Payments
NPI 1982124491 · MURRAY, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 51 payments from 20 companies in 2025. Trend: 2023 $602 · 2024 $599 · 2025 $966
Food & beverage: $921Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 12 | $212 |
| AstraZeneca Pharmaceuticals LP | 2 | $190 |
| Novo Nordisk Inc | 14 | $148 |
| Lundbeck LLC | 3 | $53 |
| ABBVIE INC. | 2 | $40 |
| Vanda Pharmaceuticals Inc. | 2 | $37 |
| Amgen Inc. | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Boston Scientific Corporation | 1 | $25 |
| Baxter Healthcare | 1 | $22 |
Products named: FARXIGA, MOUNJARO, REXULTI, KISUNLA, Wegovy, JARDIANCE, Ozempic, UBRELVY.
Industry payments across KY — which companies pay providers there.
